WCM Investment Management LLC Acquires 37,873 Shares of Inspire Medical Systems, Inc. $INSP

WCM Investment Management LLC lifted its holdings in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 52.0% during the second quarter, HoldingsChannel reports. The firm owned 110,733 shares of the company’s stock after purchasing an additional 37,873 shares during the quarter. WCM Investment Management LLC’s holdings in Inspire Medical Systems were worth $14,662,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently added to or reduced their stakes in the company. New York State Teachers Retirement System increased its holdings in Inspire Medical Systems by 0.5% in the 2nd quarter. New York State Teachers Retirement System now owns 21,490 shares of the company’s stock worth $2,789,000 after acquiring an additional 100 shares during the last quarter. Vanguard Personalized Indexing Management LLC increased its holdings in Inspire Medical Systems by 29.5% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 2,360 shares of the company’s stock worth $306,000 after acquiring an additional 538 shares during the last quarter. Oak Ridge Investments LLC increased its holdings in Inspire Medical Systems by 1.0% in the 2nd quarter. Oak Ridge Investments LLC now owns 26,353 shares of the company’s stock worth $3,420,000 after acquiring an additional 263 shares during the last quarter. Sivik Global Healthcare LLC purchased a new stake in Inspire Medical Systems in the 2nd quarter worth about $1,298,000. Finally, Aberdeen Group plc increased its holdings in Inspire Medical Systems by 100.3% in the 2nd quarter. Aberdeen Group plc now owns 243,102 shares of the company’s stock worth $31,547,000 after acquiring an additional 121,741 shares during the last quarter. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Insider Activity at Inspire Medical Systems

In other news, CFO Richard Buchholz sold 11,000 shares of the business’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $93.39, for a total transaction of $1,027,290.00. Following the completion of the transaction, the chief financial officer owned 44,867 shares of the company’s stock, valued at approximately $4,190,129.13. The trade was a 19.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 4.10% of the company’s stock.

Inspire Medical Systems Stock Down 1.9%

INSP stock opened at $77.36 on Friday. The firm has a market capitalization of $2.29 billion, a PE ratio of 44.72, a PEG ratio of 2.46 and a beta of 1.16. Inspire Medical Systems, Inc. has a twelve month low of $70.77 and a twelve month high of $216.01. The stock has a 50-day simple moving average of $82.87 and a two-hundred day simple moving average of $119.54.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings data on Monday, August 4th. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.22 by $0.23. Inspire Medical Systems had a return on equity of 10.38% and a net margin of 6.17%.The company had revenue of $217.09 million during the quarter, compared to analyst estimates of $214.50 million. During the same quarter in the previous year, the firm earned $0.32 earnings per share. Inspire Medical Systems’s revenue was up 10.8% on a year-over-year basis. Inspire Medical Systems has set its FY 2025 guidance at 0.400-0.500 EPS. On average, equities research analysts anticipate that Inspire Medical Systems, Inc. will post 2.16 EPS for the current fiscal year.

Inspire Medical Systems declared that its Board of Directors has approved a stock buyback program on Monday, August 11th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the company to reacquire up to 8.6% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s management believes its shares are undervalued.

Analyst Ratings Changes

Several brokerages recently weighed in on INSP. Leerink Partners decreased their price objective on Inspire Medical Systems from $116.00 to $97.00 and set a “market perform” rating for the company in a report on Friday, August 15th. Royal Bank Of Canada reissued an “outperform” rating and issued a $150.00 price objective on shares of Inspire Medical Systems in a report on Friday, October 10th. Weiss Ratings reissued a “sell (d)” rating on shares of Inspire Medical Systems in a report on Wednesday, October 8th. Morgan Stanley reduced their target price on Inspire Medical Systems from $200.00 to $182.00 and set an “overweight” rating for the company in a report on Tuesday, July 15th. Finally, Truist Financial reduced their target price on Inspire Medical Systems from $125.00 to $90.00 and set a “hold” rating for the company in a report on Wednesday. Seven analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $148.00.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.